HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.

Abstract
The effect of trimazosin versus placebo therapy in 16 patients and of prazosin versus placebo therapy in six patients on treadmill exercise performance was evaluated in two double-blind, randomized studies in patients with chronic left ventricular failure despite therapy with digitalis and diuretics. The administration of trimazosin and prazosin was effective in lowering resting systolic and diastolic blood pressures and resting heart rate times systolic blood pressure, and the administration of trimazosin was effective in decreasing exercise diastolic blood pressure. Trimazosin and prazosin therapy was also effective in diminishing clinical symptoms, in lessening roentgenographic evidence of pulmonary venous congestion and in improving exercise duration until marked dyspnea. Based on these data, we conclude that the vasodilators, trimazosin and prazosin, are effective in treating chronic left ventricular failure.
AuthorsW S Aronow, D T Danahy
JournalThe American journal of medicine (Am J Med) Vol. 65 Issue 1 Pg. 155-60 (Jul 1978) ISSN: 0002-9343 [Print] United States
PMID356598 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antihypertensive Agents
  • Piperazines
  • Placebos
  • Quinazolines
  • Vasodilator Agents
  • trimazosin
  • Prazosin
Topics
  • Adult
  • Aged
  • Antihypertensive Agents (pharmacology, therapeutic use)
  • Blood Pressure (drug effects)
  • Chronic Disease
  • Clinical Trials as Topic
  • Double-Blind Method
  • Exercise Test
  • Heart (physiopathology)
  • Heart Failure (drug therapy, physiopathology)
  • Heart Rate (drug effects)
  • Heart Ventricles (physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Physical Exertion (drug effects)
  • Piperazines (pharmacology)
  • Placebos
  • Prazosin (pharmacology, therapeutic use)
  • Quinazolines (pharmacology)
  • Vasodilator Agents (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: